TY - JOUR
AU1 - LilliE, R. D.
AB - 126 A.J.C.P.—Vol. 62 LETTERS TO THE EDITOR To the Editor: — Dr. VanWormer's letter However, there is now a great deal of is gratifying to us and we are glad that activity in developing new sources of he has found the iron-celestin blue B hematoxylin. Several new companies have metho d so successful. That he should find appeared , and our own regular suppliers it necessary to vary the staining time ar e also producing more numerous was perhaps to be expected in view of the batches of this dye. These new "postcrisis" wid e variation in exact details of hematoxylins share certain defects, but hematoxylin and eosin technics. Th e pref­ they appear to be remediable, and most of erences of workers as to the density of the new batches produced can be quite the nuclear staining vary considerably. It serviceable in alum hematoxylin technics. is also to be pointed out that he used a Some may require somewhat increased celestin blue from a German source. Ours quantities of dye, but the common pro­ was known to be 3 years old and came portion of 5 Gm. dye per 1. will probably from an American supplier. It, too, 
TI - Doctor Lillie’s Reply
JF - American Journal of Clinical Pathology
DO - 10.1093/ajcp/62.1.126
DA - 1974-07-01
UR - https://www.deepdyve.com/lp/oxford-university-press/doctor-lillie-s-reply-vsXlxbpVnv
SP - 126
EP - 126
VL - 62
IS - 1
DP - DeepDyve
ER -